Avalo Therapeutics Income Statement (2014-2026) | AVTX

Income Statement Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
1.35M0.22M1.17M1.03M14.95M0.90M0.47M0.64M0.24M0.57M0.25M0.19M0.06M
Cost of Revenue (Quarter)
0.91M0.42M0.72M1.57M0.53M0.62M0.55M0.71M0.25M-0.22M0.08M0.34M0.71M
Gross Profit (Quarter)
0.44M-0.20M0.45M-0.53M14.42M0.28M-0.08M-0.07M-0.01M0.79M-0.08M-0.34M-0.47M
Operating items
Amortization - Intangibles (Quarter)
0.43M0.27M0.04M
Research & Development (Quarter)
10.55M11.51M9.58M8.51M7.04M6.17M6.01M4.66M1.25M1.87M2.12M4.60M9.54M8.18M9.12M14.07M13.62M13.27M14.05M23.42M
Selling, General & Administrative (Quarter)
5.93M5.98M11.68M2.78M3.28M2.96M2.71M2.43M2.49M2.68M3.19M4.53M4.29M5.23M5.55M5.24M5.58M6.53M6.85M8.10M
Other Operating Expenses (Quarter)
1.34M0.69M0.76M1.57M0.53M0.62M0.55M0.71M0.25M3.69M27.46M0.45M-0.71M0.09M
Operating Expenses (Quarter)
17.81M18.18M22.03M12.86M10.85M9.75M9.27M7.79M3.99M8.23M32.77M9.57M13.11M13.50M14.67M19.32M19.20M19.80M20.90M31.52M
Operating Income (Quarter)
-16.46M-17.96M-20.85M-11.83M4.09M-8.86M-8.79M-7.15M-3.75M-7.66M-32.77M-9.57M-12.86M-13.31M-14.67M-19.32M-19.20M-19.74M-20.90M-31.52M
EBIT (Quarter)
-16.46M-17.96M-20.85M-11.83M4.09M-8.86M-8.79M-7.15M-3.75M-7.66M-32.77M-9.57M-12.86M-13.31M-14.67M-19.32M-19.20M-19.74M-20.90M-31.52M
Non-operating items
Non Operating Investment Income (Quarter)
Other Non Operating Income (Quarter)
-0.01M-0.18M-0.02M-0.12M-0.01M-0.01M-0.00M
Non Operating Income (Quarter)
-1.00M-1.18M-1.19M-1.15M-0.90M-0.95M-0.95M-1.04M-1.55M-0.52M0.10M108.05M35.88M-21.91M1.15M1.10M1.12M-8.54M1.28M-4.82M
Net income details
EBT (Quarter)
-17.46M-19.15M-22.04M-12.98M3.20M-9.80M-9.95M-8.19M-5.22M-8.18M-121.28M98.47M23.02M-35.23M-13.14M-20.75M-30.61M-13.59M-19.62M-36.34M
Tax Provisions (Quarter)
0.01M-0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M-0.01M0.01M0.01M-0.01M0.11M0.01M0.02M0.01M0.13M0.01M0.02M
Profit After Tax (Quarter)
-17.47M-19.13M-22.05M-12.99M3.19M-9.81M-9.96M-8.19M-5.23M-8.17M-121.29M98.46M23.04M-35.34M-13.15M-20.80M-30.55M-13.80M-19.70M-36.94M
Income from Non-Controlling Interests (Quarter)
-0.03M0.07M0.03M-0.07M-0.58M
Income from Continuing Operations (Quarter)
-17.47M-19.13M-22.05M-12.99M3.19M-9.81M-9.96M-8.19M-5.23M-8.17M-121.29M98.46M23.04M-35.34M-13.15M-20.77M-30.62M-13.72M-19.63M-36.36M
Consolidated Net Income (Quarter)
0.08M-0.07M-9.96M-8.19M-5.23M-8.17M-121.29M98.46M23.04M-35.34M-13.15M-20.77M-30.62M-13.72M-19.63M-36.36M
Income towards Parent Company (Quarter)
0.08M-0.07M-9.96M-8.19M-5.23M-8.17M-121.29M98.46M23.04M-35.34M-13.15M-20.77M-30.62M-13.72M-19.63M-36.36M
Net Income towards Common Stockholders (Quarter)
0.08M-0.07M-9.96M-8.19M-5.23M-8.17M-121.29M98.46M23.04M-35.34M-13.15M-20.77M-30.62M-13.72M-19.63M-36.36M
Additional items
EPS (Basic) (Quarter)
2.18-111.49-203.65-140.62-26.81-29.41-141.1495.214.15-7.98-1.25-1.92-2.19-1.02-0.98-0.83
EPS (Diluted) (Quarter)
2.18-1.87-203.65-140.62-26.81-29.41-141.1412.872.14-4.71-1.25-1.92-2.19-1.02-0.98-0.83
Shares Outstanding (Quarter)
0.03M583.00583.000.04M1.000.04M0.05M0.06M0.20M0.28M0.86M1.03M5.55M4.43M10.51M10.83M14.00M13.40M20.11M43.60M
Shares Outstanding (Diluted) (Quarter)
0.03M0.03M0.04M0.04M0.04M0.04M0.05M0.06M0.20M0.28M0.86M7.65M10.78M7.50M10.51M10.83M14.00M13.40M20.11M43.60M
Shares Outstanding (Entity) (Quarter)
0.04M583.00583.000.04M1.000.04M0.06M0.06M0.20M0.28M0.86M1.03M5.55M4.43M10.83M10.84M14.00M13.40M20.11M43.60M
EBITDA (Quarter)
-16.46M-17.96M-20.85M-11.83M4.09M-8.86M-8.79M-7.15M-3.75M-7.66M-32.77M-9.57M-12.86M-13.31M-14.67M-19.32M-19.20M-19.74M-20.90M-31.52M
Interest Expenses (Quarter)
3.57M0.79M2.87M3.11M0.60M0.68M2.72M1.13M2.46M-1.70M0.06M0.06M0.06M0.06M0.06M0.12M0.06M0.01M23.80M36.60M
Tax Rate (Quarter)
-0.05%0.08%-0.04%-0.04%0.16%-0.08%-0.08%-0.09%-0.15%0.11%-0.01%0.01%-0.06%-0.32%-0.06%-0.08%-0.04%-0.96%-0.06%-0.05%